Analyst Ratings for Obagi Medical Products (OMPI)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/27/2013 | Roth/MKM | N/A | Downgrade | Neutral (Buy) |
19.75 (17.00) |
19.71 (23.98) |
21.66% | Details |
| 3/21/2013 | Cantor Fitzgerald » Updated 4/2/2013 |
N/A | Downgrade | Neutral (Overweight) |
22.00 (19.75) |
19.73 (23.98) |
21.54% | Details |
![]() |
||||||||
![]() |
||||||||


